Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a “grey zone” combination of myelodysplastic and myeloproliferative features?

• Valentina F.I. Sangiorgio,
• Julia T. Geyer,
• Elizabeth Margolskee,
• Mustafa Al-Kawaaz,
• Susan Mathew,
• Wayne Tam,
• Attilio Orazi

Affiliations

Valentina F.I. Sangiorgio

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY, USA;University of Milan, Milan, Italy

Julia T. Geyer

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY, USA

Elizabeth Margolskee

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY, USA

Mustafa Al-Kawaaz

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY, USA

Susan Mathew

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY, USA

Wayne Tam

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY, USA

Attilio Orazi

Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY, USA